BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu KH, Chen HH, Cheng TT, Jan YJ, Weng MY, Lin YJ, Chen HA, Cheng JT, Huang KY, Li KJ, Su YJ, Leong PY, Tsai WC, Lan JL, Chen DY. Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis. Medicine (Baltimore) 2022;101:e28501. [PMID: 35029907 DOI: 10.1097/MD.0000000000028501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee KA, Kim HJ, Kim HS. Comparison of predictive value of FRAX, trabecular bone score, and bone mineral density for vertebral fractures in systemic sclerosis: A cross-sectional study. Medicine (Baltimore) 2023;102:e32580. [PMID: 36637920 DOI: 10.1097/MD.0000000000032580] [Reference Citation Analysis]
2 Nasonov EL, Ananyeva LP, Avdeev SN. Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology. Naučno-praktičeskaâ revmatologiâ 2022;60:517-534. [DOI: 10.47360/1995-4484-2022-1] [Reference Citation Analysis]
3 Wu D, Luo Y, Li T, Zhao X, Lv T, Fang G, Ou P, Li H, Luo X, Huang A, Pang Y. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front Immunol 2022;13:1051082. [PMID: 36618407 DOI: 10.3389/fimmu.2022.1051082] [Reference Citation Analysis]
4 Alharbe UA, Alatawi HH, Amirthalingam P, Daghriri SM, Alhwiti AA, Alenazi TS, Al Ahmare ATS, Zaitone SA, Aljabri A, Hamdan AM. Ethnicity affects the risk factors of acute myocardial infarction and should be considered in educational programs. Front Cardiovasc Med 2022;9:948028. [DOI: 10.3389/fcvm.2022.948028] [Reference Citation Analysis]
5 Shchendrigin IN, Mazharov VN. The profile of comorbid conditions and the structure of mortality in patients with rheumatoid arthritis in the Stavropol Territory: preliminary results. Med vestn Ûga Ross 2022;13:173-182. [DOI: 10.21886/2219-8075-2022-13-3-173-182] [Reference Citation Analysis]
6 Ranjit A, Khajeh Pour S, Aghazadeh-Habashi A. Bone-Targeted Delivery of Novokinin as an Alternative Treatment Option for Rheumatoid Arthritis. Pharmaceutics 2022;14:1681. [PMID: 36015308 DOI: 10.3390/pharmaceutics14081681] [Reference Citation Analysis]
7 Su Y, Huang J, Chu C, Wei JC. Sulfonylureas or biguanides is associated with a lower risk of rheumatoid arthritis in patients with diabetes: A nationwide cohort study. Front Med 2022;9. [DOI: 10.3389/fmed.2022.934184] [Reference Citation Analysis]
8 Nasonov EL, Samsonov MY. The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist). Naučno-praktičeskaâ revmatologiâ 2022;60:280-298. [DOI: 10.47360/1995-4484-2022-280-298] [Reference Citation Analysis]
9 D'Onofrio B, di Lernia M, De Stefano L, Bugatti S, Montecucco C, Bogliolo L. Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis. J Clin Med 2022;11:2341. [PMID: 35566466 DOI: 10.3390/jcm11092341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]